Thus, this study provides a novel approach to the homeostatic recovery, and suggests that the triggering of IFN-γ signalling via CUGBP1 reduction in activated HSCs could be beneficial for the resolution of liver fibrosis. The gene discussed is CELF1; the disease is Hepatic fibrosis.